Wang, Lu
Chen, Jinliang
Chen, Wenjun
Ruan, Zourong
Lou, Honggang
Yang, Dandan
Jiang, Bo
Funding for this research was provided by:
The National Major Science and Technology projects of China (2020ZX09201022)
Article History
Received: 13 January 2023
Accepted: 18 September 2023
First Online: 28 November 2023
Declarations
:
: The authors declare no competing interests.
: The in vivo data after receiving 20 mg of atorvastatin tablets was obtained from a completed PK study. It was approved by the Human Subject Research Ethics Committee of the Second Affiliated Hospital School of Medicine, Zhejiang University ( (2017) LSYD No. (238) ), and was carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects before the study.
: Not applicable in this section.